Getein Biotech, Inc (603387.SS) Dividend, Growth and Profitability Scores

Dividend

Growth

Last update : Jul 30, 2026

162lg

Metrics

Value

Rating

Revenue growth97

g7zDSJ4JUV

5Y Revenue growth80

k2TVMesUE2

EBITDA growth14

sqAh2gH06z

5Y EBITDA growth94

hWiwNgjgRL

Operating income growth30

qup57f6KD0

5Y Operating income growth2

u06F98fppj

Net income growth56

rHSPnH0Uqb

Free cash flow growth64

Zb1X52DJPP

5Y Free cash flow growth59

F7buxOIySj

Operating cash flow growth2

KolVKtldOu

5Y Operating cash flow growth65

rvtb0KVm4e

Capex growth21

TzzMftg4qE

Financial Strength

Last update : Jul 30, 2026

15XdkAhLP

Metrics

Value

Rating

Interest coverage58

SKYqVY464U

Quick ratio40

BCWNtk9Nj1

Debt / Assets20

ZNSPN

Profitability

Last update : Jul 30, 2026

17sVXJ4

Metrics

Value

Rating

Gross margin50

vnDyAgJGyE

Operating margin52

Xx4Jhjl3IE

Net margin44

WJ3eaJ1oBm

Momentum

Last update : Aug 23, 2026

5eGH

Metrics

ESG

No data available currently

Getein Biotech, Inc

603387.SS - CNE100002RR9

Getein Biotech, Inc

603387.SS - CNE100002RR9

Dividend

Growth

Financial Strength

Profitability

Momentum

ESG

Piotroski F

Unlock this feature

Altman Z

Unlock this feature

Image Modal

Getein Biotech, Inc

603387.SS - CNE100002RR9

Image Modal

Getein Biotech, Inc

603387.SS - CNE100002RR9

Dividend

Growth

Financial Strength

Profitability

Momentum

ESG

Piotroski F

Unlock this feature

Altman Z

Unlock this feature